The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia.
Int J Lab Hematol
; 37 Suppl 1: 122-32, 2015 May.
Article
en En
| MEDLINE
| ID: mdl-25976970
ABSTRACT
Acute myeloid leukemia (AML) is a complex disease, for which our understanding of the role of genetic and epigenetic changes has undergone significant advancements. Newer diagnostic and prognostic classifications have increasingly incorporated such information, and novel therapies have been developed to target specific genes, processes, and pathways based on this growing understanding. Given the rapid evolution of this field, it is critical for physicians and translational researchers to have a more in-depth understanding of this evolving landscape. Here, we review both genetics and epigenetics in acute myeloid leukemia from a practical standpoint.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Translocación Genética
/
Leucemia Mieloide
/
Epigénesis Genética
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Año:
2015
Tipo del documento:
Article